Highlights Coegin Pharma AB

Equities

COEGIN

SE0020357754

End-of-day quote NORDIC GROWTH MARKET Other stock markets 03:30:00 24/06/2024 am IST			5-day change	1st Jan Change
6.98 ^SEK	+3.25%		+8.39%	+29.62%

23/05	Coegin Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02/05	Coegin Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Coegin Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	23/05	CI
Coegin Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	02/05	CI
Coegin Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20/11	CI
Coegin Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20/11	CI
Coegin Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	25/23/25	CI
Coegin Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2023	25/23/25	CI
Coegin Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2023	25/23/25	CI
Coegin Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	27/23/27	CI
Coegin Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	27/23/27	CI
Coegin Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	24/22/24	CI
Coegin Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	25/22/25	CI
Coegin Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2022	19/22/19	CI
Coegin Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2021	24/22/24	CI
Coegin Pharma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	24/22/24	CI
Coegin Pharma AS completed the acquisition of Follicum AB.	07/22/07	CI
Coegin Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	25/21/25	CI
Coegin Pharma Receives Final Approval for COAK Study	26/21/26	CI
Coegin Pharma AS agreed to acquire Follicum AB for SEK 35.4 million.	23/21/23	CI
Coegin Pharma : Shares Surge 12% On Regulatory Nod For Lead Drug Candidate	15/21/15	MT
Coegin Pharma Receives Approval from Ethics Committee for Clinical Trial	15/21/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Coegin Pharma AB

Equities

COEGIN

SE0020357754

Highlights

Filters